Francisco Expósito (Francisco Exposito)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 10

Top Venues

Cancers

Journal for immunotherapy of cancer

Nature cancer

Cancer research

Universidad de Navarra

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Universidad de Navarra Sep 22 2016

Spain

PhD Student :: Pathology, Anatomy and Phisiology

Publications

Francisco Expósito, Miriam Redrado, Maeva Houry, Katherine Hastings, Magdalena Molero, Teresa Lozano, José Luis Solórzano, Julián Sanz, Vera Adradas, Ramon Amat, Esther Redin, Sergio Leon, Naroa Legarra, Javier Garcia, Angel Rodriguez, Karmele Valencia, Camila Robles-Oteíza, Giorgia Foggetti, Nerea Otegui, Enriqueta Felip Font, Juan Jose Lasarte, Luis G Paz-Ares, Jon Zugazagoitia, Katerina Politi, Luis M Montuenga, Alfonso Calvo
PTEN loss confers resistance to anti-PD-1 therapy in non-small cell lung cancer by increasing tumor infiltration of regulatory T cells. Cancer research (2023)
Nerea Otegui, Maeva Houry, Imanol Arozarena, Angel Rodriguez, Esther Redin, Francisco Expósito, Sergio Leon, Karmele Valencia, Luis M Montuenga, Alfonso Calvo
Cancer Cell-Intrinsic Alterations Associated with an Immunosuppressive Tumor Microenvironment and Resistance to Immunotherapy in Lung Cancer. Cancers 15 (12) (2023)
Nerea Otegui, Maeva Houry, Imanol Arozarena, Angel Rodriguez, Esther Redin, Francisco Expósito, Sergio Leon, Karmele Valencia, Luis M Montuenga, Alfonso Calvo
Cancer Cell-Intrinsic Alterations Associated with an Immunosuppressive Tumor Microenvironment and Resistance to Immunotherapy in Lung Cancer. Cancers 15 (12) (2023)
Clément Anfray, Francesco Mainini, Elisabeth Digifico, Akihiro Maeda, Marina Sironi, Marco Erreni, Achille Anselmo, Aldo Ummarino, Sara Gandoy, Francisco Expósito, Miriam Redrado, Diego Serrano, Alfonso Calvo, Marvin Martens, Susana Bravo, Alberto Mantovani, Paola Allavena, Fernando Torres Andón
Intratumoral combination therapy with poly(I:C) and resiquimod synergistically triggers tumor-associated macrophages for effective systemic antitumoral immunity. Journal for immunotherapy of cancer 9 (9) (2022)
Karmele Valencia, Cristina Sainz, Cristina Bértolo, Gabriel de Biurrun, Jackeline Agorreta, Arantza Azpilikueta, Marta J Larrayoz, Graziella Bosco, Carolina Zandueta, Miriam Redrado, Esther Redín, Francisco Expósito, Diego Serrano, Mirari Echepare, Daniel Ajona, Ignacio Melero, Ruben Pio, Roman Thomas, Alfonso Calvo, Luis M Montuenga
Two alternative cell line models for the study of multiorganic metastasis and immunotherapy in Lung Squamous Cell Carcinoma. Disease models & mechanisms (2021)
Cora Palanca-Ballester, Aitor Rodriguez-Casanova, Susana Torres, Silvia Calabuig-Fariñas, Francisco Expósito, Angel Rodriguez, Esther Redin, Karmele Valencia, Eloísa Jantus-Lewintre, Angel Diaz-Lagares, Luis M Montuenga, Juan Sandoval, Alfonso Calvo
Cancer Epigenetic Biomarkers in Liquid Biopsy for High Incidence Malignancies. Cancers 13 (12) (2021)
Esther Redin, Irati Garmendia, Teresa Lozano, Diego Serrano, Yaiza Senent, Miriam Redrado, Maria Villalba, Carlos E De Andrea, Francisco Expósito, Daniel Ajona, Sergio Ortiz-Espinosa, Ana Remirez, Cristina Bertolo, Cristina Sainz, Juana Garcia-Pedrero, Ruben Pio, Juan Jose Lasarte, Jackeline Agorreta, Luis M Montuenga, Alfonso Calvo
SRC family kinase (SFK) inhibitor dasatinib improves the antitumor activity of anti-PD-1 in NSCLC models by inhibiting Treg cell conversion and proliferation. Journal for immunotherapy of cancer 9 (3) (2021)
Emilio Esteban, Francisco Expósito, Guillermo Crespo, Julio Lambea, Alvaro Pinto, Javier Puente, Jose A Arranz, Miriam Redrado, Cristina Rodriguez-Antona, Carlos de Andrea, Marta Lopez-Brea, Esther Redin, Angel Rodriguez, Jorge G González, Jorge Garcia, Enrique Grande, Daniel Castellano, Alfonso Calvo
Circulating Levels of the Interferon-γ-Regulated Chemokines CXCL10/CXCL11, IL-6 and HGF Predict Outcome in Metastatic Renal Cell Carcinoma Patients Treated with Antiangiogenic Therapy. Cancers 13 (11) (2021)
Daniel Ajona, Sergio Ortiz-Espinosa, Teresa Lozano, Francisco Expósito, Alfonso Calvo, Karmele Valencia, Miriam Redrado, Ana Remírez, Fernando Lecanda, Diego Alignani, Juan Jose Lasarte, Irati Macaya, Yaiza Senent, Cristina Bértolo, Cristina Sainz, Ignacio Gil-Bazo, Iñaki Eguren-Santamaría, Jose M Lopez-Picazo, Alvaro Gonzalez, Jose-Luis Perez-Gracia, Carlos E de Andrea, Silvestre Vincent, Miguel F Sanmamed, Luis M Montuenga, Ruben Pio
Short-term starvation reduces IGF-1 levels to sensitize lung tumors to PD-1 immune checkpoint blockade. Nature cancer 1 (1) (2020)
Maria Villalba, Esther Redin, Francisco Expósito, Maria Jose Pajares, Cristina Sainz, Antonio José Cañada-Martínez, Elizabeth Guruceaga, Angel Diaz-Lagares, Cristina Cirauqui, Miriam Redrado, Karmele Valencia, Carlos de Andrea, Eloísa Jantus-Lewintre, Carlos Camps, Rafael Lopez-Lopez, Agustin Lahoz, Luis Montuenga, Ruben Pio, Juan Sandoval, Alfonso Calvo
Identification of a novel synthetic lethal vulnerability in non-small cell lung cancer by co-targeting TMPRSS4 and DDR1. Scientific reports 9 (1) (2019)

Francisco Expósito.css-eqlu8i{font-size:small;padding-left:4px;} (Francisco Exposito)

Publication Activity (10 Years)

Top Topics

Top Venues

Francisco Expósito (Francisco Exposito)